DK0646132T3 - Aminosukkere, glycoproteiner, fremgangsmåde til fremstilling deraf, lægemidler med indhold deraf samt anvendelse deraf - Google Patents

Aminosukkere, glycoproteiner, fremgangsmåde til fremstilling deraf, lægemidler med indhold deraf samt anvendelse deraf

Info

Publication number: DK0646132T3
Authority: DK; Denmark
Prior art keywords: immune system; glycoproteins; amino sugars; processes; preparation
Prior art date: 1993-04-12

Application number

DK94913578T

Other languages

English (en)

Inventor

Werner Reutter

Cora Schueler

Oliver Keppler

Michael Pawlika

Holger Kayser

Original Assignee

Werner Reutter

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-12

Filing date

1994-04-12

Publication date

2000-03-13

1994-04-12 Application filed by Werner Reutter filed Critical Werner Reutter

2000-03-13 Application granted granted Critical

2000-03-13 Publication of DK0646132T3 publication Critical patent/DK0646132T3/da

Links

102000003886 Glycoproteins Human genes 0.000 title abstract 2
108090000288 Glycoproteins Proteins 0.000 title abstract 2
150000002337 glycosamines Chemical class 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
210000000987 immune system Anatomy 0.000 abstract 3
230000004936 stimulating effect Effects 0.000 abstract 2
CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical compound N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 abstract 1
241000894006 Bacteria Species 0.000 abstract 1
206010009192 Circulatory collapse Diseases 0.000 abstract 1
208000035473 Communicable disease Diseases 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
206010040047 Sepsis Diseases 0.000 abstract 1
210000001744 T-lymphocyte Anatomy 0.000 abstract 1
206010053648 Vascular occlusion Diseases 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
210000004102 animal cell Anatomy 0.000 abstract 1
210000001772 blood platelet Anatomy 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
230000004069 differentiation Effects 0.000 abstract 1
210000003989 endothelium vascular Anatomy 0.000 abstract 1
210000005260 human cell Anatomy 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
230000001394 metastastic effect Effects 0.000 abstract 1
206010061289 metastatic neoplasm Diseases 0.000 abstract 1
CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 abstract 1
244000045947 parasite Species 0.000 abstract 1
239000008177 pharmaceutical agent Substances 0.000 abstract 1
239000002243 precursor Substances 0.000 abstract 1
208000013223 septicemia Diseases 0.000 abstract 1
206010040560 shock Diseases 0.000 abstract 1
210000004881 tumor cell Anatomy 0.000 abstract 1
208000021331 vascular occlusion disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Oncology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Microbiology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK94913578T 1993-04-12 1994-04-12 Aminosukkere, glycoproteiner, fremgangsmåde til fremstilling deraf, lægemidler med indhold deraf samt anvendelse deraf DK0646132T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4311580A DE4311580C1 (de)	1993-04-12	1993-04-12	Glycoproteine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
PCT/EP1994/001126 WO1994024167A1 (de)	1993-04-12	1994-04-12	Aminozucker, glycoproteine, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung

Publications (1)

Publication Number	Publication Date
DK0646132T3 true DK0646132T3 (da)	2000-03-13

Family

ID=6485046

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94913578T DK0646132T3 (da)	1993-04-12	1994-04-12	Aminosukkere, glycoproteiner, fremgangsmåde til fremstilling deraf, lægemidler med indhold deraf samt anvendelse deraf

Country Status (8)

Country	Link
EP (1)	EP0646132B1 (da)
JP (1)	JPH08501803A (da)
AT (1)	ATE183204T1 (da)
AU (1)	AU6567494A (da)
CA (1)	CA2137833A1 (da)
DE (1)	DE4311580C1 (da)
DK (1)	DK0646132T3 (da)
WO (1)	WO1994024167A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09183789A (ja) *	1995-10-31	1997-07-15	Sanwa Kagaku Kenkyusho Co Ltd	新規な硫酸化及び燐酸化糖誘導体、その製法及び用途
AUPP589398A0 (en) *	1998-09-14	1998-10-08	Walter And Eliza Hall Institute Of Medical Research, The	Immunogenic compositions and uses thereof
DE19852729A1 (de) *	1998-11-16	2000-05-18	Werner Reutter	Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
DE10045047A1 (de)	2000-09-12	2002-03-21	Beate Kehrel	Arzneimittel enthaltend aktiviertes Antithrombin III
AU2002336981A1 (en) *	2001-08-17	2003-03-03	Charite	Glycoconjugates of sialic acid derivates, methods for their production and use thereof
DK1545599T3 (da) *	2002-07-26	2015-08-03	Inst Medical W & E Hall	Immunogene præparater og diagnostiske og terapeutiske anvendelser deraf
ES2357752T3 (es) *	2004-09-09	2011-04-29	Novartis Vaccines And Diagnostics Gmbh	Reducción de riesgos latrogénicos potenciales asocidos con vacunas.

1993
- 1993-04-12 DE DE4311580A patent/DE4311580C1/de not_active Expired - Fee Related
1994
- 1994-04-12 AU AU65674/94A patent/AU6567494A/en not_active Abandoned
- 1994-04-12 EP EP94913578A patent/EP0646132B1/de not_active Expired - Lifetime
- 1994-04-12 CA CA002137833A patent/CA2137833A1/en not_active Abandoned
- 1994-04-12 AT AT94913578T patent/ATE183204T1/de not_active IP Right Cessation
- 1994-04-12 WO PCT/EP1994/001126 patent/WO1994024167A1/de active IP Right Grant
- 1994-04-12 JP JP6522730A patent/JPH08501803A/ja active Pending
- 1994-04-12 DK DK94913578T patent/DK0646132T3/da active

Also Published As

Publication number	Publication date
JPH08501803A (ja)	1996-02-27
CA2137833A1 (en)	1994-10-27
EP0646132A1 (de)	1995-04-05
WO1994024167A1 (de)	1994-10-27
DE4311580C1 (de)	1994-08-18
ATE183204T1 (de)	1999-08-15
EP0646132B1 (de)	1999-08-11
AU6567494A (en)	1994-11-08

Similar Documents

Publication	Publication Date	Title
PT82457A (en)	1986-05-01	Process for the preparation of pharmaceutical compound with base in phosphonil-methoxy-alkyl-adenines with antiviral activity
AU6642390A (en)	1991-05-31	Methods and compositions for promoting immunopotentiation
DE3684732D1 (de)	1992-05-14	Adoptivimmuntherapie als behandlungsmodalitaet bei menschen.
BRPI0507822A (pt)	2007-07-10	método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição autoimune ou infecciosa, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição do sangue, método e composição farmacêutica para modular a formação de células do sangue, método e composição farmacêutica para intensificar a mobilização periférico da célula tronco, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição metabólica, método e composição farmacêutica para a prevenção ou o tratamento das condições associadas com doses mieloablativas de quimioradioterapia suportadas pelo transplante autólogo de medula óssea ou de células tronco do sangue periférico (asct) ou pelo transplante alogenéico de medula óssea (bmt), método e composição farmacêutica para aumentar o efeito de um fator estimulante de células do sangue, método e composição farmacêutica para intensificar a colonização de células tronco do sangue doadas em um receptor mieloablatado, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição bacteriana, composição farmacêutica para o tratamento ou a prevenção de uma indicação selecionada do grupo que consiste em doença ou condição autoimune, doença viral, infecção viral, doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, hiperlipidemia, hipercolesterolemia, glucosuria, hiperglicemia, diabetes, aids, hiv-1, distúrbios de células t auxiliares, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, distúrbios do sistema imunológico resultantes da terapia de quimioterapia ou de radiação, distúrbios do sistema imunológico humano resultantes do tratamento das doenças de deficiência imunológica e infecções bacterianas, composição farmacêutica para o tratamento ou a prevenção de um indicação selecionada do grupo que consiste em doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, sìndrome mielodisplástiacas, malignidades não mielóides, anemia plástica e insuficiência da medula óssea, peptìdeo purificado, peptìdeo quimérico purificado, peptìdeo quimérico, composição farmacêutica, composição farmacêutica para a prevenção ou o tratamento de uma condição associada com um agente infeccioso de sars, método de processamento a baixa temperatura de hidrolisato proteolìtico de caseìna e hidrolisato de proteìna de caseìna
SE9201413L (sv)	1993-10-31	Beredning och sätt för aferesframställning av trombocytkoncentrat med väsentligt förlängd hållbarhet
DK0646132T3 (da)	2000-03-13	Aminosukkere, glycoproteiner, fremgangsmåde til fremstilling deraf, lægemidler med indhold deraf samt anvendelse deraf
STRINGFELLOW et al.	1980	Interferon induction by 5-halo-6-phenyl pyrimidinones
IT8483359A0 (it)	1984-05-31	Procedimento per ottenere lapreparazione di concentrati e nutrimenti proteici dal sangue animale.
FI875245A0 (fi)	1987-11-27	Foerfarande foer oekande av utsoendringen av adenosin.
DE69929616D1 (de)	2006-04-13	Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
Farnsworth	1950	Acute and subacute glomerulonephritis modified by adrenocorticotropin.
Alan et al.	1986	Interferon α/β selectively antagonises down-regulation of mannosyl-fucosyl receptors on activated macrophages by interferon γ
ATE71299T1 (de)	1992-01-15	Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
US4874608A (en)	1989-10-17	Therapeutic method for treating malignancies
RU98109235A (ru)	2000-02-20	Способ лечения бактериальной инфекции
Borgies et al.	1989	Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation
Naoum et al.	1996	Treatment of herpes zoster with interferon alpha-2A.
Friedman et al.	1987	Antitumor effects of interferons
ES550932A0 (es)	1987-03-16	Procedimiento para la determinacion cinetica de la actividad del sistema de complemento de sangre de ser humano o de animal mamifero.
SU1600502A1 (ru)	1996-05-20	Способ приготовления эритроцитарного диагностикума для индикации лекарственной аллергии к антибиотикам
Azuma et al.	1995	Acute hemolysis during cyclosporine therapy successfully treated with vitamin E
Alalawi et al.	1977	Combined effects of bleomycin and X-rays on DNA synthesis in asynchronous Ehrlich ascites cells in suspension
AU2366388A (en)	1989-06-01	A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect
RU98108179A (ru)	2000-02-10	Способ лечения инфекционного мононуклеоза у детей
SU1507380A1 (ru)	1989-09-15	Способ лечени расстройств слуха